SEC Form 4 · accession 0001053369-15-000024
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nasrat A Hakim
Officer — President & CEO · Director · 10% Owner
Period of report
Apr 23, 2015
Accepted (ET)
Apr 27, 2015 · 6:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 23, 2015 | J | 2,570,018 | $0.00 | A | 2,570,018 | I | By Mikah Pharma, LLC |
| Common Stock | holding | — | — | — | 2,700,000 | I | By IRA | |
| Common Stock | holding | — | — | — | 13,760,695 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition of common stock to the members of Epic Pharma, LLC